Definition of tumor antigens suitable for vaccine construction
Open Access
- 1 December 1995
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 6 (6), 321-327
- https://doi.org/10.1016/1044-579x(95)90001-2
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.The Journal of Experimental Medicine, 1994
- Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.The Journal of Experimental Medicine, 1994
- Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell LinesScience, 1994
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice.The Journal of Experimental Medicine, 1991
- Expression of Epstein–Barr Virus Transformation–Associated Genes in Tissues of Patients with EBV Lymphoproliferative DiseaseNew England Journal of Medicine, 1989
- Structure of the gene of tum− transplantation antigen P91A: The mutated exon encodes a peptide recognized with Ld by cytolytic T cellsCell, 1989
- A pigmentation‐associated, differentiation antigen of human melanoma defined by a precipitating antibody in human serumInternational Journal of Cancer, 1983
- Presence of human papillomavirus DNA sequences in cervical intraepithelial neoplasia.BMJ, 1983
- BCG lmmunotherapy of Malignant MelanomaAnnals of Surgery, 1974